A Phase 1, single-center, open-label assessing the elimination, metabolism, and mass balance of 14C-atogepant in Healthy Male Participants
Latest Information Update: 09 Jun 2021
At a glance
- Drugs Atogepant (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- 09 Jun 2021 New trial record
- 22 Apr 2021 Results presented at the 73rd Annual Meeting of the American Academy of Neurology